Drug Appraisal Recommendations in Urological Oncology and Impact on Cancer Treatment Unit Visits at Sussex Cancer Network – 10-year Update

Purpose: Systemic treatment of solid tumours and clinical outcomes have significantly improved over the past two decades since the development and establishment of new cancer therapies [1,2]. The launch of the Cancer Drug Fund in 2016 enabled wider and faster access to cancer drugs [3]. At present, 78% of cancer drug appraisal recommendations are positive. Over the past 10 years, 8 new cancer drugs and 9 new indications have been recommended by NICE in urology, particularly in prostate and renal cancer [4 –8].
Source: Clinical Oncology - Category: Radiology Authors: Source Type: research